CATHAY BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.16 CNY | +12.99% |
|
+20.76% | -10.59% |
| Apr. 15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
| Apr. 02 | Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023. | CI |
ETFs positioned on Cathay Biotech Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.69% | 1 M€ | -7.73% | - | |
| 0.81% | 45 M€ | -13.85% | - | |
| 0.81% | 45 M€ | -10.44% | - | |
| 0.81% | 39 M€ | -11.99% | - | |
| 0.00% | 34 M€ | +2.43% | - |
Cathay Biotech Inc is a China-based company engaged in research, development, production and sales of biobased materials. The Company's primary products are biological long-chain dibasic acids and bio-based polyamide series, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The Company sells its products to domestic and overseas markets.
Sector
Specialty Chemicals
Calendar
2024-04-29
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.59% | 3.5B | |
| +5.01% | 25.92B | |
| +11.55% | 1.7B | |
| -18.40% | 563M | |
| -21.41% | 384M | |
| -81.65% | 216M | |
| -11.15% | 114M |
- Stock Market
- Equities
- 688065 Stock
- Funds and ETFs Cathay Biotech Inc.
